TickerFacts.

Company research / BCPC

Balchem Corp (BCPC)

Build a valuation ↗↓ Download CSV

SEC name BALCHEM CORP · CIK 0000009326 · Nasdaq · Chemicals & Allied Products

  • Sector Manufacturing
  • Incorporated MD
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Balchem Corp reported revenue of $1.04B. Revenue grew 8.8% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.09B.

Key ratios (year ended 2025-12-31)

35.7%
Gross margin
20.2%
Operating margin
14.9%
Net margin
12.3%
Return on year-end equity
8.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-07-31

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$1.09B$1.04B$953.68M$922.44M$942.36M$799.02M$703.64M$643.71M$643.68M$594.79M$553.20M
Cost of Revenue$691.76M$666.53M$617.48M$620.38M$661.91M$555.85M$479.75M$432.34M$439.43M$405.78M$372.34M
Gross Profit$394.12M$370.63M$336.21M$302.06M$280.45M$243.17M$223.90M$211.37M$204.25M$189.01M$180.86M
R&D Expense$19.96M$18.51M$16.79M$15.05M$12.19M$13.52M$10.33M$11.38M$11.59M$9.30M$7.33M
Operating Income$221.72M$209.33M$182.91M$159.19M$145.19M$127.50M$111.15M$102.55M$107.10M$96.90M$90.84M
Depreciation & Amortization$47.98M$45.69M$47.97M$54.94M$51.85M$48.88M$51.28M$45.86M$44.67M$44.38M$46.20M
EBITDA$269.70M$255.02M$230.88M$214.13M$197.03M$176.38M$162.43M$148.41M$151.77M$141.28M$137.04M
Net Income$164.41M$154.84M$128.47M$108.54M$105.37M$96.10M$84.62M$79.67M$78.57M$90.07M$55.97M
EPS (Diluted)n/a$4.75$3.93$3.35$3.25$2.94$2.60$2.45$2.42$2.79$1.75
Total Assets$1.69B$1.69B$1.58B$1.60B$1.62B$1.20B$1.17B$1.16B$981.36M$963.64M$948.63M
Total Liabilities$384.63M$428.84M$425.46M$543.23M$686.23M$322.31M$337.61M$412.01M$289.74M$346.75M$427.59M
Shareholders' Equity$1.30B$1.26B$1.15B$1.05B$938.28M$877.01M$828.23M$743.67M$691.62M$616.88M$521.03M
Cash & Equivalents$63.17M$74.57M$49.52M$64.45M$66.56M$103.24M$84.57M$65.67M$54.27M$40.42M$38.64M
Operating Cash Flow$219.62M$216.56M$182.00M$183.76M$138.54M$160.51M$150.49M$124.46M$118.70M$110.62M$107.61M
Capital Expendituresn/an/an/an/a$49.09M$36.14M$32.08M$25.79M$19.17M$27.53M$23.03M
Free Cash Flown/an/an/an/a$89.45M$124.37M$118.41M$98.67M$99.53M$83.09M$84.58M
Share Repurchases$113.53M$107.64M$5.68M$4.47M$35.42M$35.24M$13.46M$21.32M$1.39M$1.91M$1.59M
Dividends Paid$30.79M$28.29M$25.58M$22.87M$20.71M$18.72M$16.70M$15.13M$13.43M$12.07M$10.72M
Shares Outstanding31.96M32.06M32.53M32.25M32.15M32.29M32.37M32.20M32.26M32.02M31.76M
Dividends Per Sharen/a$0.96$0.87$0.79$0.71n/an/an/an/an/an/a
Weighted Average Diluted Sharesn/a32.60M32.72M32.45M32.39M32.67M32.50M32.51M32.45M32.23M31.92M
EPS (Basic)n/a$4.80$3.97$3.38$3.29$2.98$2.63$2.48$2.45$2.83$1.78

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView